Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy
Background: and purpose: Radiation recall dermatitis is an adverse event predominantly due to systemic therapy administration after a previous radiation therapy course. Few case reports describe radiation recall dermatitis in breast cancer patients treated with postoperative radiation therapy follow...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Breast |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977622001175 |
_version_ | 1828177126166102016 |
---|---|
author | Lorenzo Vinante Angela Caroli Alberto Revelant Federica Bertini Anna Giroldi Marta Marson Giovanni Franchin Elena Muraro Giulia Brisotto Agostino Steffan Lorena Baboci |
author_facet | Lorenzo Vinante Angela Caroli Alberto Revelant Federica Bertini Anna Giroldi Marta Marson Giovanni Franchin Elena Muraro Giulia Brisotto Agostino Steffan Lorena Baboci |
author_sort | Lorenzo Vinante |
collection | DOAJ |
description | Background: and purpose: Radiation recall dermatitis is an adverse event predominantly due to systemic therapy administration after a previous radiation therapy course. Few case reports describe radiation recall dermatitis in breast cancer patients treated with postoperative radiation therapy following COVID-19 vaccination. In this study we investigated the incidence and severity of radiation recall dermatitis after COVID-19 vaccination in irradiated breast cancer patients. Methods: Patients that received at least one COVID-19 vaccination dose during the year after the end of postoperative breast radiation therapy were included in this observational monocentric study. Local symptoms occurring inside the radiation field after vaccination were patient-reported and scored according to the PRO-CTCAE questionnaire. Descriptive data of radiation recall dermatitis incidence and severity, and potential risk factors were evaluated. Results: A cohort of 361 patients with 756 administered COVID-19 vaccinations was analyzed. Breast symptoms were reported by 7.5% of patients, while radiation recall dermatitis was considered for 5.5%. The incidence of radiation recall dermatitis per single dose of vaccine was 2.6%, with a higher risk for the first dose compared to the second/third (4.4% vs 1%, p = 0.003), especially when administered within the first month after the end of irradiation (12.5% vs 2.2%, p = 0.0004). Local symptoms were generally self-limited and a few cases required anti-inflammatory drugs. Conclusions: Radiation recall dermatitis is an uncommon but not rare phenomenon in breast cancer patients that received COVID-19 vaccination within one year after breast irradiation. However, symptoms severity were generally low/mild and reversible. These findings can be useful for patient counseling. |
first_indexed | 2024-04-12T04:54:27Z |
format | Article |
id | doaj.art-3ca7c78b23ee4d00b2f08db5ef8c6fc2 |
institution | Directory Open Access Journal |
issn | 1532-3080 |
language | English |
last_indexed | 2024-04-12T04:54:27Z |
publishDate | 2022-10-01 |
publisher | Elsevier |
record_format | Article |
series | Breast |
spelling | doaj.art-3ca7c78b23ee4d00b2f08db5ef8c6fc22022-12-22T03:47:11ZengElsevierBreast1532-30802022-10-01654954Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapyLorenzo Vinante0Angela Caroli1Alberto Revelant2Federica Bertini3Anna Giroldi4Marta Marson5Giovanni Franchin6Elena Muraro7Giulia Brisotto8Agostino Steffan9Lorena Baboci10Radiation Oncology Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, ItalyRadiation Oncology Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, ItalyRadiation Oncology Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, ItalyRadiation Oncology Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, ItalyRadiation Oncology Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, ItalyRadiation Oncology Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, ItalyRadiation Oncology Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, ItalyImmunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, ItalyImmunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, ItalyImmunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, ItalyImmunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, PN, Italy; Corresponding author. Immunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.Background: and purpose: Radiation recall dermatitis is an adverse event predominantly due to systemic therapy administration after a previous radiation therapy course. Few case reports describe radiation recall dermatitis in breast cancer patients treated with postoperative radiation therapy following COVID-19 vaccination. In this study we investigated the incidence and severity of radiation recall dermatitis after COVID-19 vaccination in irradiated breast cancer patients. Methods: Patients that received at least one COVID-19 vaccination dose during the year after the end of postoperative breast radiation therapy were included in this observational monocentric study. Local symptoms occurring inside the radiation field after vaccination were patient-reported and scored according to the PRO-CTCAE questionnaire. Descriptive data of radiation recall dermatitis incidence and severity, and potential risk factors were evaluated. Results: A cohort of 361 patients with 756 administered COVID-19 vaccinations was analyzed. Breast symptoms were reported by 7.5% of patients, while radiation recall dermatitis was considered for 5.5%. The incidence of radiation recall dermatitis per single dose of vaccine was 2.6%, with a higher risk for the first dose compared to the second/third (4.4% vs 1%, p = 0.003), especially when administered within the first month after the end of irradiation (12.5% vs 2.2%, p = 0.0004). Local symptoms were generally self-limited and a few cases required anti-inflammatory drugs. Conclusions: Radiation recall dermatitis is an uncommon but not rare phenomenon in breast cancer patients that received COVID-19 vaccination within one year after breast irradiation. However, symptoms severity were generally low/mild and reversible. These findings can be useful for patient counseling.http://www.sciencedirect.com/science/article/pii/S0960977622001175Breast cancerRadiation therapyRadiation recall dermatitisCOVID-19 vaccination |
spellingShingle | Lorenzo Vinante Angela Caroli Alberto Revelant Federica Bertini Anna Giroldi Marta Marson Giovanni Franchin Elena Muraro Giulia Brisotto Agostino Steffan Lorena Baboci Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy Breast Breast cancer Radiation therapy Radiation recall dermatitis COVID-19 vaccination |
title | Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy |
title_full | Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy |
title_fullStr | Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy |
title_full_unstemmed | Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy |
title_short | Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapy |
title_sort | radiation recall dermatitis induced by covid 19 vaccination in breast cancer patients treated with postoperative radiation therapy |
topic | Breast cancer Radiation therapy Radiation recall dermatitis COVID-19 vaccination |
url | http://www.sciencedirect.com/science/article/pii/S0960977622001175 |
work_keys_str_mv | AT lorenzovinante radiationrecalldermatitisinducedbycovid19vaccinationinbreastcancerpatientstreatedwithpostoperativeradiationtherapy AT angelacaroli radiationrecalldermatitisinducedbycovid19vaccinationinbreastcancerpatientstreatedwithpostoperativeradiationtherapy AT albertorevelant radiationrecalldermatitisinducedbycovid19vaccinationinbreastcancerpatientstreatedwithpostoperativeradiationtherapy AT federicabertini radiationrecalldermatitisinducedbycovid19vaccinationinbreastcancerpatientstreatedwithpostoperativeradiationtherapy AT annagiroldi radiationrecalldermatitisinducedbycovid19vaccinationinbreastcancerpatientstreatedwithpostoperativeradiationtherapy AT martamarson radiationrecalldermatitisinducedbycovid19vaccinationinbreastcancerpatientstreatedwithpostoperativeradiationtherapy AT giovannifranchin radiationrecalldermatitisinducedbycovid19vaccinationinbreastcancerpatientstreatedwithpostoperativeradiationtherapy AT elenamuraro radiationrecalldermatitisinducedbycovid19vaccinationinbreastcancerpatientstreatedwithpostoperativeradiationtherapy AT giuliabrisotto radiationrecalldermatitisinducedbycovid19vaccinationinbreastcancerpatientstreatedwithpostoperativeradiationtherapy AT agostinosteffan radiationrecalldermatitisinducedbycovid19vaccinationinbreastcancerpatientstreatedwithpostoperativeradiationtherapy AT lorenababoci radiationrecalldermatitisinducedbycovid19vaccinationinbreastcancerpatientstreatedwithpostoperativeradiationtherapy |